US EditionPublished • loading... • Updated
APOE, Aβ42, Tau Affect Cognitive Decline in Parkinson’s
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
APOE, Aβ42, Tau Affect Cognitive Decline in Parkinson’s
In a groundbreaking study set to redefine our understanding of Parkinson’s disease (PD) and its cognitive dimensions, researchers have uncovered distinct molecular mechanisms that drive cognitive decline in different genetic forms of this complex neurodegenerative disorder. The study, recently published in npj Parkinson’s Disease, focuses on the differential impacts of APOE, amyloid-beta 42 (Aβ42), and […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
